Astrana Health (ASTH) Liabilities and Shareholders Equity (2011 - 2026)

Astrana Health has reported Liabilities and Shareholders Equity for 16 years, with the latest figure at $2.4 billion in Q1 2026.

• Quarterly Liabilities and Shareholders Equity rose 77.19% year-over-year to $2.4 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.3 billion (up 58.06% YoY) and the FY2025 annual result came in at $2.2 billion, up 63.75% from the prior year.
• Liabilities and Shareholders Equity grew to $2.4 billion in Q1 2026 per ASTH's latest filing, from $2.2 billion in the prior quarter.
• Over five years, Liabilities and Shareholders Equity peaked at $2.4 billion in Q1 2026 and troughed at $922.7 million in Q1 2022.
• A 5-year average of $1.3 billion and a median of $1.2 billion in 2024 frame the typical range for Liabilities and Shareholders Equity.
• The sharpest annual moves came in 2023 and 2026: Liabilities and Shareholders Equity retreated 3.4% in 2023, then jumped 77.19% in 2026.
• Over 5 years, Liabilities and Shareholders Equity stood at $966.2 million in 2022, then declined by 3.4% to $933.4 million in 2023, then jumped by 45.16% to $1.4 billion in 2024, then surged by 63.75% to $2.2 billion in 2025, then gained by 6.32% to $2.4 billion in 2026.
• According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $2.4 billion, $2.2 billion, and $2.2 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.